| BCL5 |
|
B cell CLL/lymphoma 5
|
|
|
0.890 |
0.154 |
| BCRP4 |
|
BCR pseudogene 4
|
|
|
0.805 |
0.154 |
| FRA8C |
|
fragile site, aphidicolin type, common, fra(8)(q24.1)
|
|
|
0.861 |
0.192 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| IGL |
|
immunoglobulin lambda locus
|
|
|
0.659 |
0.346 |
| IGLC4 |
|
immunoglobulin lambda constant 4 (pseudogene)
|
|
|
0.839 |
0.385 |
| IGLC5 |
|
immunoglobulin lambda constant 5 (pseudogene)
|
|
|
0.839 |
0.385 |
| MHS4 |
|
malignant hyperthermia susceptibility 4
|
|
|
0.890 |
0.154 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| TRD |
|
T cell receptor delta locus
|
|
|
0.650 |
0.692 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| IGHV3-75 |
|
immunoglobulin heavy variable 3-75 (pseudogene)
|
|
|
0.769 |
0.231 |
| IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
| IGHV1-12 |
|
immunoglobulin heavy variable 1-12 (pseudogene)
|
|
|
0.569 |
0.654 |
| TRDD3 |
|
T cell receptor delta diversity 3
|
|
|
0.736 |
0.269 |
| IGK |
|
immunoglobulin kappa locus
|
|
|
0.647 |
0.462 |
| BMS1P20 |
|
BMS1 pseudogene 20
|
|
|
0.682 |
0.577 |
| MIR155HG |
|
MIR155 host gene
|
|
|
0.617 |
0.615 |
| CKS1BP7 |
|
CDC28 protein kinase regulatory subunit 1B pseudogene 7
|
|
|
0.610 |
0.577 |
| BCRP2 |
|
BCR pseudogene 2
|
|
|
0.736 |
0.423 |
| MIRLET7C |
|
microRNA let-7c
|
|
|
0.514 |
0.808 |
| MIR127 |
|
microRNA 127
|
|
|
0.553 |
0.692 |
| MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
| MIR143 |
|
microRNA 143
|
|
|
0.462 |
0.885 |